Abstract
Objective: Anastomotic insufficiency in colorectal surgery can lead to serious complications and high morbidity and mortality rates. This study aimed to evaluate the effect of tirofiban hydrochloride, an antiplatelet agent, on ischemic colon anastomosis healing.
Materials and Methods: A total of 21 male Wistar albino rats were randomly divided into three groups: Group A (Sham), Group B (Ischemia-Control), and Group C (Ischemia-Tirofiban). Ischemia was induced in the colon by ligating the marginal arteries, followed by end-to-end anastomosis. Group C received intraperitoneal tirofiban (0.125 mcg/1cc) for five postoperative days. On the fifth postoperative day, bursting pressure, hydroxyproline (HP) levels, and histopathological ischemic necrosis scores were assessed.
Results: Bursting pressures were measured as 97.85±16.17 mmHg in Group B and 170.85±8.15 mmHg in Group C (p<0.0001). HP levels were 2.42±0.84 mg/g in Group A, 3.70±0.29 mg/g in Group B, and 4.80±0.99 mg/g in Group C. Histopathological scores were significantly better in Group C (p=0.024).
Conclusion: Tirofiban significantly improved ischemic colon anastomosis healing in terms of bursting pressure, collagen production, and histological tissue integrity. These findings suggest that tirofiban may be a potential agent to enhance anastomotic safety in ischemic surgical settings.
Keywords
Colon anastomosis, Ischemia, Tirofiban, Bursting pressure, Hydroxyproline